December 20, 2019
Rose
The North American trade pact is moving swiftly through Congress. The legislation is noticeably missing a provision that would have granted market exclusivity for biologics for 10 years. The removal of the protection was a big win for Democrats and a huge loss for the pharmaceutical industry. In other news: an Ebola vaccine, nerve drugs, biotech stocks, a subscription model for medication, and more.
from Kaiser Health News https://ift.tt/35GH9k5
December 20, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Florida Attorney General Aims To Block Ballot Initiative On Semi-Automatic Gun Used In Parkland Mass Shooting- State Highlights: A Look At How Changes In State Abortion Laws Cast Pall Over Women; Adult Homes For Mentally Ill Get Second Chance In New York
- Different Takes: Pros And Cons Of Kamala Harris’ New Take On ‘Medicare For All’
- Viewpoints: Keep Momentum Going To Stop Sky-High Surprise Medical Bills; Count The Reasons For Trying Disease-Control Approach To Gun Violence
- An Algorithm Could Pinpoint Those Most At Risk Of HIV And Have Doctors Steer Them Toward PrEP
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment